UCL in the media
Freedom of Information Act
On the 10 year anniversary of the Freedom of Information Act, Professor Robert Hazell (UCL Constitution Unit) discusses how it has changed public perception of government.
Listen: BBC Radio 4 'Today' (from 1 hour 52 mins)Listeners' science questions
Dr Helen Czerski (UCL Mechanical Engineering) and Dr Andrew Pontzen (UCL Physics & Astronomy) help answer listeners' science questions.
Listen: BBC Radio 4 'Inside Science'Heroes and villains
Professor Geoffrey Raisman (UCL Brain Repair & Rehabilitation) has been named a hero of 2014 by the Jewish Chronicle for his research into olfactory cell transplants.
Read: Jewish ChronicleA history of fireworks: how about some flaming artichokes to blast in the new year?
Dr Simon Werrett (UCL Science & Technology Studies) looks at the history of fireworks.
Read: The ConversationScientists 'must be emotionally charged' about climate change
Professor Chris Rapley (UCL Earth Sciences) says climate scientists must inject more emotion and personal experience into their communications with the public to underline the dangers of global warming.
Read: IndependentNew year, old you: Some alternative resolutions
Dr Kaori O'Connor (UCL Anthropology) says that there is a cycle of renewal across all cultures and religions marking the transition from winter to spring.
Read: IndependentA Christmas pudding story
Dr Kaori O'Connor (UCL Anthropology) unfolds the tale of the British Christmas pudding.
Listen: BBC World Service 'The Food Chain' (from 22 mins 45 secs)Young opt for life in London microhouses
Professor Peter Rees (UCL Bartlett School of Planning) says property developers who are building hostels and microhouses for young workers in London are following in the footsteps of landlords in earlier times.
Read: Financial TimesUse the arts to boost the nation's health
Museums on Prescription, a three year research project, has been launched by UCL and aims to connect isolated, vulnerable older people to their local heritage.
Read: ObserverApproval of antiobesity drug
Dr Nicholas Finer (UCL Cardiovascular Science) comments on the decision by European regulators to approve the antiobesity drug, Mysimba.
Read: BMJ